Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia.
about
Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion.Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: pathophysiology and management.Heparin-induced thrombocytopenia: pathogenesis and management.Frequency of heparin-induced thrombocytopenia in critical care patients.Prevalance of heparin-dependent platelet-activating antibodies in preterm newborns after exposure to unfractionated heparin.New developments in diagnosis and treatment of heparin-induced thrombocytopenia.Diagnosis and management of heparin-induced thrombocytopenia.Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.Heparin-induced thrombocytopenia: treatment options and special considerations.Heparin induced thrombocytopenia with thrombosis: a two step process?Current concepts review: heparin-induced thrombocytopenia.Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model.Heparin-induced thrombocytopenia: present and future.The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies.PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI.Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopenia.Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study.Heparin-induced thrombocytopenia in the pediatric population: a review of current literatureRefractoriness to platelet transfusion in acute myeloid leukemia correlated with the optical density of anti-platelet factor 4/heparin antibodies.Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia.The transfusion-related acute lung injury controversy: lessons from heparin-induced thrombocytopenia.Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.Tissue factor - a therapeutic target for thrombotic disorders.Tissue factor, blood coagulation, and beyond: an overview.Drug-induced thrombosis--experimental, clinical, and mechanistic considerations.Drug-induced thrombosis: an update.Superficial vein thrombosis.The presence of heparin-platelet factor 4 antibodies as a marker of hypercoagulability during hemodialysis.5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
P2860
Q28278419-E2BC11B1-8697-4A8E-8573-AAF903643A63Q30483035-E43767E8-09C6-4357-A32F-FB989F939F72Q30497774-06CA4C02-D515-4901-B99A-84A98478B48DQ33342924-0C518046-1D41-4B4A-BAB4-3335A79B890BQ33348049-DF3DA7C4-558B-40F2-9EB4-3ED22C3C0F87Q33348648-D28F56AB-74C8-47C5-9ED3-F620B48693B5Q33363358-5AC82FD0-918B-43D5-BEF2-B1A07C484852Q33364828-F2095757-1E87-4AE8-873F-214B61EECEDCQ33365985-788BAC58-A37C-4D6A-8426-F15DAF764834Q33369316-F8D8F362-E026-43F6-8661-76702B23B978Q33374658-6CCD5CA6-D767-43FA-A30A-B40146F0AD38Q33380753-EFF04427-711C-4FDB-9913-2D55E7AB01D0Q33382108-212C820E-768D-407E-9D6A-955F5987EBF9Q33385134-B0FF8115-0DD8-499F-8441-620EC77D52DFQ33385510-CB328659-BEC5-48BE-A323-F7F186C20CD3Q33392880-70CEC204-A572-4284-B9F3-D6813031288AQ33394188-B0812589-113E-4CE3-8336-F66EA2D68CDDQ33396756-EC2BAC44-CB36-424E-A662-AC1AA267D143Q33400120-C70E838A-9500-4D2F-A774-0E2F511FF02AQ33402501-C0F40D16-9A76-4F70-A392-4D82EC41DB5FQ33403437-12106EF3-8963-4D36-A1EE-F67C22A6F388Q33404178-0F9A5C44-B813-4947-AAF0-5D0293FCE14AQ33410242-1337E1D4-0A30-4856-8606-4EAC59D14352Q33410765-2325F0C1-7139-4DB4-BA16-08B732CB6615Q33416269-CB8C1792-2319-4A48-B6D2-770C52A5246EQ33420150-75235C50-6A64-42E4-AD10-1D922714A773Q33425288-180CCC55-A0B4-49E5-B3CC-A567AADB1E1BQ34837564-8D5B80B4-F321-4DE5-B535-7C0C5B5963BFQ35222618-4E1EE786-6DF9-43CE-B4FC-69A96D81D68AQ36762200-52FA7677-AA1B-48C1-B4DC-7FE9D0FD60FAQ38103820-3DE64B44-5C4F-4E24-B35A-92254921A528Q43905870-E3A15EA4-FDC3-47AE-A859-86A1F10663AEQ50760369-5D0935A7-12AE-4C96-8572-C418A8C7CFCEQ52552212-BDD61E32-B47E-409B-906D-BE6F525BE86B
P2860
Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Induction of monocyte tissue f ...... arin-induced thrombocytopenia.
@ast
Induction of monocyte tissue f ...... arin-induced thrombocytopenia.
@en
Induction of monocyte tissue f ...... arin-induced thrombocytopenia.
@nl
type
label
Induction of monocyte tissue f ...... arin-induced thrombocytopenia.
@ast
Induction of monocyte tissue f ...... arin-induced thrombocytopenia.
@en
Induction of monocyte tissue f ...... arin-induced thrombocytopenia.
@nl
prefLabel
Induction of monocyte tissue f ...... arin-induced thrombocytopenia.
@ast
Induction of monocyte tissue f ...... arin-induced thrombocytopenia.
@en
Induction of monocyte tissue f ...... arin-induced thrombocytopenia.
@nl
P2093
P1433
P1476
Induction of monocyte tissue f ...... parin-induced thrombocytopenia
@en
P2093
P304
P356
10.1182/BLOOD.V97.10.3300
P407
P577
2001-05-01T00:00:00Z